Page 26 - Central Drug Authority Annual Report 2021

4.2 BOARD OF DIRECTORS:

a) DRUG EXPERTS

NAME OF MEMBER NAME OF MEMBER
0U 'DYLG %D\HYHU CDA Chairperson
0U 3HWHU 8FNR ([SHUW
0U &ROOHQ 0S\DQH ([SHUW
0U 0RVHV *DPD ([SHUW
0V $QJHOD 6DOWHU ([SHUW
0V /HWKLZH 1GORYX ([SHUW
3URI (YD 0DQ\HGL ([SHUW
0U *HUWKDUG .UXJHU ([SHUW

b) DEPARTMENTAL REPRESENTATIVES

NAME DEPARTMENT
3URI 3HOPRV 0DVKDEHOD &RUUHFWLRQDO 6HUYLFHV
'U .JDODEL 1JDNR +HDOWK
0U 0RJRWVL .DODHDPRGLPR 6RFLDO 'HYHORSPHQW
0U 6HOOR 0DODND +RPH $IIDLUV
0V 6HVL 0DKORERJRDQH +LJKHU (GXFDWLRQ
0U 3HWHU 3RVWKXPXV 6$ 5HYHQXH 6HUYLFHV
0V 3UHD 3DPGKXQ\ 7UDGH ,QGXVWU\ DQG &RPSHWLWLRQ
$GY $QWKHD 9DQ GHU %\O 6$ +HDOWK 3URGXFWV 5HJXODWRU\ $XWKRULW\ 6$+35$
0U 7KRPVD 5DPEDX International Relations & Cooperation
'U &KDUPDLQH %DGHUQKRVW -XVWLFH &RQVWLWXWLRQDO 'HYHORSPHQW
%ULJDGLHU -XG\ $OOHQ 6RXWK $IULFDQ 3ROLFH 6HUYLFHV
&RORQHO 0DWODPHOD 6RXWK $IULFDQ 3ROLFH 6HUYLFHV
1RPIXQGR 0RIRNHQJ 'HSDUWPHQW RI 7UDQVSRUW
0U 3DVHND 1MREH 'HSDUWPHQW RI %DVLF (GXFDWLRQ

$V SUHYLRXVO\ LQGLFDWHG WKH H[SHUWV DUH PHPEHUV RI WKH SXEOLF ZKR DUH FRQVLGHUHG DV VXFK E\ 3DUOLDPHQW ZKLFK VKRUWOLVWV
LQWHUYLHZV DQG UHFRPPHQGV WR WKH 0LQLVWHU RI 6RFLDO 'HYHORSPHQW WKH DSSRLQWPHQW RI SDUWLFXODU FDQGLGDWHV WR WKH %RDUG RI
WKH &'$ 'HSDUWPHQWDO UHSUHVHQWDWLYHV DUH QRPLQDWHG E\ WKHLU UHVSHFWLYH PLQLVWHUV DQG DSSRLQWHG E\ WKH 0LQLVWHU RI 6RFLDO
'HYHORSPHQW

24 Annual Report 2020/2021 Central Drug Authority